Adaptimmune Therapeutics PLC 10-K for FY2021
Adaptimmune Therapeutics PLC (ADAPY)
10-K
2022-03-14
For: 2021-12-31
View Original
Added on
June 11, 2026
About this 10-K
Adaptimmune Therapeutics PLC filed this 10-K on March 14, 2022, covering the fiscal year ended December 31, 2021 (FY2021).
Headline figures
Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.15M
- up 55.4% from $3.96M a year earlier
- Net loss
- $158.09M
- compared with a net loss of $130.09M a year earlier
- Diluted EPS
- -$0.17
- compared with -$0.15 a year earlier